Cite
HARVARD Citation
Papayannidis, C. et al. (2021). Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant. Hematological oncology. 39 (4), pp. 580-583. [Online].